Publicaciones en las que colabora con Salvador Resino García (13)

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

2022

  1. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240

2020

  1. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

    Critical Care, Vol. 24, Núm. 1

2018

  1. Association of CD14 rs2569190 polymorphism with mortality in shock septic patients who underwent major cardiac or abdominal surgery: A retrospective study

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. IL-1B rs16944 polymorphism is related to septic shock and death

    European Journal of Clinical Investigation, Vol. 47, Núm. 1, pp. 53-62

  2. IL-6 rs1800795 polymorphism is associated with septic shock-related death in patients who underwent major surgery: a preliminary retrospective study

    Annals of Intensive Care, Vol. 7, Núm. 1

2015

  1. Mitochondrial DNA haplogroups are associated with severe sepsis and mortality in patients who underwent major surgery

    Journal of Infection, Vol. 70, Núm. 1, pp. 20-29

  2. Transcriptomic correlates of organ failure extent in sepsis

    Journal of Infection, Vol. 70, Núm. 5, pp. 445-456

2012

  1. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis

    Cytokine, Vol. 57, Núm. 3, pp. 332-336

2011

  1. Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza

    BMC Infectious Diseases, Vol. 11

  2. Early natural killer cell counts in blood predict mortality in severe sepsis.

    Critical care (London, England), Vol. 15, Núm. 5

2010

  1. Host adaptive immunity deficiency in severe pandemic influenza

    Critical Care, Vol. 14, Núm. 5

  2. Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin

    European Cytokine Network, Vol. 21, Núm. 2, pp. 84-91